Blood markers in children with congenital hearing loss
Treatments studied
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This study looks at certain substances in the blood of children with congenital hearing loss (hearing loss present from birth) to see if they are different from children with normal hearing. It may help doctors understand why hearing loss happens and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 years old.
- Your child has hearing loss from birth, confirmed by hearing tests.
- You use a cochlear implant or a hearing aid every day.
- No other major health conditions like infections, immune problems, or cancer.
- No steroid or immune-suppressing medicines in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares blood and fluid-related immune “profiles” after cochlear implant surgery versus another ear/middle-ear surgery group. It aims to learn which immune signals may be linked to hearing outcomes and recovery after implantation.
This study looks for genetic causes of hearing loss in babies who did not pass their newborn hearing screening. It aims to help families understand why their child has hearing loss and may guide future care.
This research study examines blood samples from newborns to identify biological markers (proteins and genetic signals) that could help detect and understand congenital cytomegalovirus (CMV) infection—a virus some babies are born with. Finding these markers might help doctors identify infected infants earlier and develop better treatments.
This study is developing a system to evaluate and improve hearing for people with congenital hearing loss. It compares participants who have hearing loss (and have used hearing aids, cochlear implants, or gene therapy) with healthy controls, to better understand and treat hearing challenges.
This study tests an experimental treatment made from your own blood cells to help restore hearing after sudden deafness. It is for people who have had severe hearing loss in one ear for less than three weeks and have not had ear injections yet.
This study collects and stores tissue and blood samples from people with hearing, balance, smell, taste, voice, speech, or language conditions, as well as from healthy volunteers. The samples help researchers better understand these conditions and may lead to improved treatments.
Hear when a new Congenital Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.